Bosun Asset Management’s Medtronic MDT Stock Holding History

Bosun Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,181	Closed	-$104K	–	147
2023 Q2	$104K	Buy	+1,181	New	+$102K	0.1%	141

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bosun Asset Management's MDT Position: Q3 2023 in Review

Bosun Asset Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 1,181 shares — an estimated $104K sold.

Bosun Asset Management first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $104K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Bosun Asset Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Bosun Asset Management sold 1,181 Medtronic shares in Q3 2023, an estimated $104K.
Bosun Asset Management first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
Bosun Asset Management's Medtronic position peaked at $104K in Q2 2023.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Bosun Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.